Skip to main content
Log in

Aflatoxin and Ochratoxin Production by Aspergillus Species Under Ex Vivo Conditions

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Aspergillus species are increasingly important human pathogens. It is not known whether toxic metabolites of many of these pathogenic species can act as virulence factors in aspergillosis. We examined isolates of aflatoxin and ochratoxin-producing species for toxin production in ex vivo conditions. Seven of the 21 aflatoxin-producing isolates screened produced aflatoxin at 35 and 37°C on the general medium yeast extract sucrose agar (YES). However, none of them produced toxin at these temperatures on brain heart infusion agar (BHA), a medium that mimics human tissue, or on BHA with modified pH or sugar levels. Six of the 12 ochratoxin-producing isolates examined produced toxin at 35°C on YES. All three isolates of A. alliaceus produced ochratoxin on BHA or modified BHA at 37°C. One strain of A. pseudoelegans produced a minute amount of ochratoxin on modified BHA at 37°C. These data indicate that aflatoxin is an unlikely virulence, factor but that ochratoxin may be a potential virulence factor in aspergillosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998;26:781–805. doi:10.1086/513943.

    Article  PubMed  CAS  Google Scholar 

  2. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis. 2005;9:609–22. doi:10.1016/S1473-3099(05)70238-3.

    Article  Google Scholar 

  3. Marr KA, Patterson T, Denning DW. Aspergillosis pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am. 2002;16:875–94. doi:10.1016/S0891-5520(02)00035-1.

    Article  PubMed  Google Scholar 

  4. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis D, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America (IDSA). Clin Infect Dis. 2008;46:327–60. doi:10.1086/525258.

    Article  PubMed  CAS  Google Scholar 

  5. Arendrup MC, Petersen E, O’Driscoll BR, Denning DW. Acute pulmonary aspergillosis in immunocompetent subjects after exposure to bark chippings. Scand J Infect Dis. 2006;38:945–9. doi:10.1080/00365540600606580.

    Article  PubMed  Google Scholar 

  6. Klich MA. Identification of clinically relevant Aspergilli. Med Mycol. 2006;44:S127–31. doi:10.1080/13693780600796546.

    Article  Google Scholar 

  7. Stevens DA, Kan VL, Judson MA, Morrison VA, Dummer S, Denning DW, et al. Practice guidelines for diseases caused by Aspergillus. Clin Infect Dis. 2000;30:696–709. doi:10.1086/313756.

    Article  PubMed  CAS  Google Scholar 

  8. Bennett JW, Klich MA. Mycotoxins. Clinical Microbiol Rev. 2003;16:497–516. doi:10.1128/CMR.16.3.497-516.2003.

    Article  CAS  Google Scholar 

  9. Klich MA, Pitt JI. Differentiation of Aspergillus flavus from A parasiticus and other closely related species. Trans Br Mycol Soc. 1988;91:99–108.

    Article  Google Scholar 

  10. CAST (Council for Agricultural Science and Technology). Mycotoxins: risks in plant animal and human systems. Task Force Report 139. CAST, Ames, Iowa. 2003. 199 pp.

  11. Bok JW, Balajee SA, Marr KA, Andes D, Nielsen KF, Frisvad JC, et al. LaeA, a regulator of morphogenetic fungal virulence factors. Eukaryotic Cell. 2005;4:1574–82. doi:10.1128/EC.4.9.1574-1582.2005.

    Article  PubMed  CAS  Google Scholar 

  12. Lewis RE, Wiederhold NP, Chi J, Han XY, Koanduri KV, Kontoyiannis DP, et al. Detection of gliotoxin in experimental and human aspergillosis. Infect Immun. 2005;73:635–7. doi:10.1128/IAI.73.1.635-637.2005.

    Article  PubMed  CAS  Google Scholar 

  13. Comera C, Andre K, Jaffitte J, Collet X, Galtier P, Maridonneau-Parini I. Gliotoxin from Aspergillus fumigatus affects phagocytosis and the organization of the actin cytoskeleton by distinct signalling pathways in human neutronphils. Microb Infect. 2007;9:47–54. doi:10.1016/j.micinf.2006.10.009.

    Article  CAS  Google Scholar 

  14. Waring P, Eichner RD, Mullbacher A, Sjaarda A. Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties. J Biol Chem. 1988;263:18493–9.

    PubMed  CAS  Google Scholar 

  15. Kupfahl C, Heinekamp T, Geginat G, Ruppert T, Hartl A, Hof H, et al. Deletion of the gliP gene of Aspergillus fumigatus results in loss of gliotoxin production but has no effect on virulence of the fungus in a low-dose mouse infection model. Mol Microbiol. 2006;62:292–302. doi:10.1111/j.1365-2958.2006.05373.x.

    Article  PubMed  CAS  Google Scholar 

  16. Sugui JA, Pardo J, Chang YC, Zarember KA, Nardone G, Galvez EM, et al. Gliotoxin is a virulence factor of Aspergillus fumigatus: gliP deletion attenuates virulence in mice immunosuppressed with hydrocortisone. Eukaryotic Cell. 2007;6:1562–9. doi:10.1128/EC.00141-07.

    Article  PubMed  CAS  Google Scholar 

  17. Hsieh D. Potential human health hazards of mycotoxins. In: Natori S, Hashimoto K, Ueno Y, editors. Mycotoxins and phytotoxins. Third Joint Food and Agriculture Organization/WHO/United Nations Program, International Conference of Mycotoxins. Amsterdam, The Netherlands: Elsevier; 1988. p. 60–80.

  18. Denning DW. Aflatoxin and human disease. A review. Adv Drug React Acute Pois Rev. 1987;4:175–209.

    Google Scholar 

  19. Creppy EE. Human ochratoxicosis. J Toxicol Toxin Rev. 1999;18:277–93.

    CAS  Google Scholar 

  20. Beardall JM, Miller JD. Disease in humans with mycotoxins as possible causes. In: Miller JD, Trenhold HL, editors. Mycotoxins in grains. Compounds other than aflatoxin. St Paul Minn: Eagan Press; 1994. p. 487–539.

    Google Scholar 

  21. Kuiper-Goodman T, Scott PM. Risk assessment of the mycotoxin ochratoxin A. Biomed Environ Sci. 1989;2:179–248.

    PubMed  CAS  Google Scholar 

  22. Logrieco A, Visconti A, editors. An overview on toxigenic fungi and mycotoxins in Europe. Boston, MA: Kluwer; 2004.

    Google Scholar 

  23. Mantle PG, Chow AM. Ochratoxin formation in Aspergillus ochraceus with particular reference to spoilage of coffee. Intl J Food Microbiol. 2000;56:105–9. doi:10.1016/S0168-1605(00)00278-6.

    Article  CAS  Google Scholar 

  24. Pildain MB, Frisvad JC, Vaamonde G, Cabral D, Varga J, Samson RA. Two novel- aflatoxin-producing Aspergillus species from Argentinean peanuts. Int J Syst Evol Microbiol. 2008;58:725–35. doi:10.1099/ijs.0.65123-0.

    Article  PubMed  CAS  Google Scholar 

  25. Hedayati M, Pasquallotto A, Warn PA, Bowyer P, Denning DW. Aspergillus flavus, human pathogen, allergen and mycotoxins producer. Microbiology. 2007;153:1677–92. doi:10.1099/mic.0.2007/007641-0.

    Article  PubMed  CAS  Google Scholar 

  26. Frisvad JC, Frank JM, Houbraken JAMP, Kuijpers AFA, Samson RA. New ochratoxin A producing species of Aspergillus section Circumdati. Stud Mycol. 2004;50:23–43.

    Google Scholar 

  27. Steyn PS. Ochratoxin and other dihydroisocoumarins. In: Ciegler A, Kadis S, Ajl SJ, editors. Microbial toxins fungal toxins, vol. 6. New York: Academic Press; 1971. p. 179–204.

    Google Scholar 

  28. Ramos AJ, Labernia N, Marin S, Sanchis V, Magin N. Effect of water activity and temperature on growth and ochratoxin production by three strains of Aspergillus ochraceus on a barley extract medium and on barley grains. Int J Food Microbiol. 1998;44:133–40. doi:10.1016/S0168-1605(98)00131-7.

    Article  PubMed  CAS  Google Scholar 

  29. Klich MA. Environmental and developmental factors influencing aflatoxin production by Aspergillus flavus and Aspergillus parasiticus. Mycoscience. 2007;48:71–80. doi:10.1007/s10267-006-0336-2.

    Article  CAS  Google Scholar 

  30. Bonvehί JS. Occurrence of ochratoxin A in cocoa products and chocolate. J Agric Food Chem. 2004;52:6347–52. doi:10.1021/jf040153w.

    Article  CAS  Google Scholar 

  31. Sobolev VS, Dorner JW. Cleanup procedure for determination of aflatoxins in major agricultural commodities by liquid chromatography. JAOAC Int. 2002;85:642–5.

    CAS  Google Scholar 

  32. Mori T, Matsuura M, Yamada K, Irie S, Oshimi K, Suda K, et al. Systemic aspergillosis caused by an anflatoxin-producing strain of Aspergillus flavus. Med Mycol. 1998;36:107–12.

    PubMed  CAS  Google Scholar 

  33. Lazo RF, Sierra G. Investigacion del efecto de las micotoinas en el ser humano. Rev Iberoam Micol. 2008;25:7–11.

    Article  PubMed  Google Scholar 

  34. Balajee SA, Lindsley MD, Iqbal N, Ito J, Pappas PG, Brandt ME. Nonsporulating clinical isolate identified as Petromyces alliaceus (anamorph Aspergillus alliaceus) by morphological and sequence-based methods. J Clinical Microbiol. 2007;45:2701–3.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We thank Shannon Beltz for technical assistance and Carol Carter-Wientjes for the HPLC analyses.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maren A. Klich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klich, M.A., Tang, S. & Denning, D.W. Aflatoxin and Ochratoxin Production by Aspergillus Species Under Ex Vivo Conditions. Mycopathologia 168, 185–191 (2009). https://doi.org/10.1007/s11046-009-9215-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-009-9215-7

Keywords

Navigation